Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Alkalinization  COVID-19 treatment studies for Alkalinization  C19 studies: Alkalinization  Alkalinization   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 23% Improvement Relative Risk Mortality, exc. critical 55% Mortality, moderate 79% Mortality, severe 53% Mortality, critical -23% Recovery time 28% CT score, day 30 33% CT score, day 60 100% c19early.org/ph El-Badrawy et al. NCT05035524 Alkalinization RCT LATE Is late treatment with alkalinization beneficial for COVID-19? RCT 546 patients in Egypt (September 2021 - April 2022) Faster recovery with alkalinization (p<0.000001) Lower mortality for non-critical patients (p=0.02) El-Badrawy et al., Research Square, doi:10.21203/rs.3.rs-2214180/v1 Favors alkalinization Favors control
A randomized controlled trial of adjuvant inhalable sodium bicarbonate role in treatment of COVID-19
El-Badrawy et al., Research Square, doi:10.21203/rs.3.rs-2214180/v1 (Preprint), NCT05035524 (history)
El-Badrawy et al., A randomized controlled trial of adjuvant inhalable sodium bicarbonate role in treatment of COVID-19, Research Square, doi:10.21203/rs.3.rs-2214180/v1 (Preprint), NCT05035524
Nov 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
RCT 546 patients showing significantly faster recovery and lower mortality with sodium bicarbonate (inhaled and nasal drops). The reduction in mortality is only statistically significant when excluding baseline critical cases.
Inhalation of nebulized sodium bicarbonate 8.4% (5ml every 4h) 7:00am to 23:00pm every day for 30 days together with 8.4% nasal drops 4 times daily (three drops for each nostril).
risk of death, 23.2% lower, RR 0.77, p = 0.26, treatment 32 of 272 (11.8%), control 42 of 274 (15.3%), NNT 28, all cases.
risk of death, 54.8% lower, RR 0.45, p = 0.02, treatment 12 of 247 (4.9%), control 27 of 251 (10.8%), NNT 17, mild/moderate/severe cases.
risk of death, 79.2% lower, RR 0.21, p = 0.21, treatment 1 of 125 (0.8%), control 5 of 130 (3.8%), NNT 33, moderate cases.
risk of death, 53.2% lower, RR 0.47, p = 0.02, treatment 11 of 63 (17.5%), control 22 of 59 (37.3%), NNT 5.0, severe cases.
risk of death, 22.7% higher, RR 1.23, p = 0.33, treatment 20 of 25 (80.0%), control 15 of 23 (65.2%), critical cases.
recovery time, 27.6% lower, relative time 0.72, p < 0.001, treatment mean 4.2 (±2.5) n=272, control mean 5.8 (±3.1) n=274, time to clinical improvement.
CT score, 33.3% lower, RR 0.67, p = 0.001, treatment 238, control 229, CT score, day 30.
CT score, 100% lower, RR < 0.001, p < 0.001, treatment 238, control 229, CT score, day 60.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
El-Badrawy et al., 18 Nov 2022, Randomized Controlled Trial, Egypt, preprint, 7 authors, study period 1 September, 2021 - 30 April, 2022, trial NCT05035524 (history).
Contact: dribrahim_badr@yahoo.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperAlkalinizationAll
Abstract: A randomized controlled trial of adjuvant inhalable sodium bicarbonate role in treatment of COVID-19 Mohammad El-Badrawy Faculty of Medicine, Mansoura University Rehab Elmorsey Faculty of Medicine, Mansoura University Mohammed shehta Faculty of Medicine, Mansoura University Tamer El-Hadidy Faculty of Medicine, Mansoura University ibrahim abdelwahab (  dribrahim_badr@yahoo.com ) Faculty of Medicine, Mansoura University Adel El-Badrawy Faculty of Medicine, Mansoura University Ahmed Shokeir Faculty of Medicine, Mansoura University Article Keywords: Covid-19, sodium bicarbonate, human, RCT Posted Date: November 18th, 2022 DOI: https://doi.org/10.21203/rs.3.rs-2214180/v1 License:   This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/14 Abstract Entry of coronavirus (SARS-CoV-2) into a host cell is pH dependent. Intracellular alkalinization by sodium bicarbonate (SB) could elevate endosomal pH and block viral entry into the host cells. So, we assessed the role of inhalable SB as an adjuvant treatment for COVID-19 in the study groups of this randomized, controlled trial. Here we show a significantly shorter duration to clinical improvement and hospital stay in the study group, while the number of deaths is significantly less only in severe grade of the study group. But the time to death is not significantly different in both groups. CRP and d-dimer levels are significantly lower in the severe cases of the study group. The overall median CT score is significantly better in the study group at one & 2 months. Our data thus suggest that inhaled SB (8.4%) could be a possible adjuvant therapy for patients with moderate and severe COVID‑19 pneumonia.
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit